• Canagliflozin Hemihydrate: Precision Tools for Glucose Metab

  2026-07-15

  Canagliflozin (hemihydrate) enables ultra-selective studies of renal glucose reabsorption and glucose homeostasis, standing apart from mTOR pathway inhibitors for diabetes and metabolic disorder research. This article details optimized workflows, performance benchmarks, and troubleshooting insights to maximize assay fidelity with APExBIO’s high-purity SGLT2 inhibitor.

• 4-Hydroxytamoxifen: Technical Guide for Research Protocols

  2026-07-15

  4-Hydroxytamoxifen addresses the need for a high-purity, DMSO-soluble estrogen receptor modulator in protocols such as breast cancer research, prostate cancer models, and cardiac myocyte assays. It is not suitable for workflows requiring water or ethanol solubility, and strict storage and handling are necessary to maintain reagent integrity.

• Reimagining DNA and RNA Gel Stains for Safer Translational S

  2026-07-14

  This thought-leadership article explores the mechanistic and strategic advances in nucleic acid visualization, focusing on the transition from hazardous ethidium bromide to APExBIO’s Safe DNA Gel Stain. Integrating recent evidence on molecular biology workflows and metabolic disease research, it offers actionable insights for translational researchers seeking to enhance data quality, safety, and downstream applications such as cloning.

• ECL Western Blotting Substrate: Technical Guide and Workflow

  2026-07-14

  ECL Western Blotting Substrate (SKU K2187) provides a sensitive, nonradioactive method for detecting horseradish peroxidase (HRP) in Western blot assays, minimizing background and enabling precise protein detection by chemiluminescence. It is best suited for workflows in molecular and cancer biology or signal transduction pathway research, but should not be used in fluorescent or radioisotopic assays.

• Structure-Based Inhibitor Discovery Targeting SARS-CoV-2 NSP

  2026-07-13

  This study applies structure-based virtual screening to identify natural product inhibitors of the SARS-CoV-2 NSP15 endoribonuclease, revealing thymopentin and oleuropein as potent and stable binders. The findings offer new molecular leads for antiviral research, with implications for the rational design of inhibitors targeting viral immune evasion.

• Topotecan’s Mechanism and Clinical Value: Insights for Oncol

  2026-07-13

  This review dissects topotecan as a novel, water-soluble topoisomerase I inhibitor, highlighting its unique mechanism, clinical performance, and pharmacology. The findings have direct implications for designing combination chemotherapy regimens and understanding cross-resistance in cancer research.

• GANT61 (SKU A1615): Reliable GLI Inhibition in Cancer Resear

  2026-07-12

  This article addresses the most pressing laboratory challenges in GLI-mediated transcription inhibition and tumor growth suppression, demonstrating how GANT61 (SKU A1615) provides reproducible, data-backed solutions. By analyzing real-world scenarios and integrating quantitative benchmarks, we guide researchers in optimizing experimental design and vendor selection for robust cancer research outcomes.

• PP 1: Selective Src Family Tyrosine Kinase Inhibitor for Res

  2026-07-10

  PP 1 is a potent, nanomolar-selective Src family tyrosine kinase inhibitor validated for dissecting oncogenic signaling and T cell activation. Its high specificity for Lck and Fyn makes it a benchmark tool in cancer and immunology workflows. Careful application is required due to potential off-target effects on kinases such as CSK.

• Neuromedin S (rat): Technical Use in GPCR Signaling Workflow

  2026-07-09

  Neuromedin S (rat) offers a chemically defined, endogenous peptide agonist for precise activation of neuromedin U receptor signaling in controlled laboratory studies. It is designed for in vitro and ex vivo GPCR/G protein signaling workflows relevant to energy homeostasis and stress response research, but is not suitable for diagnostic or therapeutic use. Researchers should adhere to workflow-specific solubility and storage parameters to maintain reproducibility.

• Tariquidar (XR9576): Applied Strategies for Overcoming Chemo

  2026-07-09

  Tariquidar (XR9576) from APExBIO empowers researchers to dissect and overcome multidrug resistance in high-viscosity tumor models by selectively targeting P-glycoprotein. This guide translates cutting-edge mechanobiology insights and reference protocols into actionable workflows and advanced troubleshooting for robust drug resistance research.

• Thymosin-β4 Promotes Angiogenesis in Limb Ischemia via Notch

  2026-07-08

  This study demonstrates that Thymosin-β4 enhances angiogenesis in a mouse model of critical limb ischemia by modulating Notch and NF-κB signaling. The findings clarify the molecular mechanisms underpinning Tβ4's vascular effects and provide a basis for targeted pathway inhibition in translational vascular research.

• KCNE4 Modulation Alters Kv1.3 Blocker Pharmacology in Leukoc

  2026-07-08

  The reference study reveals that the auxiliary subunit KCNE4 significantly modifies the pharmacological response of Kv1.3 channels to intracellular blockers such as Psora 4, by slowing inhibition kinetics without altering affinity. These findings highlight the complexity of targeting Kv1.3 in immunomodulation and underscore the importance of considering channel architecture in research on effector memory T cell function.

• Structure-Based Discovery of Potent NSP15 Inhibitors for SAR

  2026-07-07

  This study introduces a structure-based virtual screening approach that identified thymopentin and oleuropein as potent inhibitors of SARS-CoV-2 NSP15, a key viral endoribonuclease. The findings offer a new direction for antiviral research by targeting NSP15-mediated immune evasion, with implications for drug repurposing and future therapeutic development.

• GANT61: Selective GLI Inhibitor for Hedgehog Pathway Researc

  2026-07-07

  GANT61 is a potent GLI inhibitor that blocks GLI1/2-mediated transcription at micromolar concentrations. It is widely used in cancer research to suppress tumor growth and investigate Hedgehog pathway signaling. Evidence shows GANT61 disrupts tumor immune evasion by targeting GLI2, offering a robust tool for translational oncology.

• Technical Guide: Cathepsin B Inhibitor CA-074 (SKU A1926) Us

  2026-07-06

  Cathepsin B inhibitor CA-074 enables precise, selective inhibition of cathepsin B for mechanistic studies in cancer metastasis, neurotoxicity, and immune response modulation. It is not suitable for studies requiring broad-spectrum cysteine protease inhibition or long-term solution storage without stability controls.

447 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page